What is ImmuCell Corporation's share price today?
ImmuCell Corporation (ICCC) share price today is $10.15 as of November 5, 2026 at 2:29 AM IST. The stock touched a day high of $10.45 and a day low of $10.15.What exchange does ImmuCell Corporation stock trade on, and under what ticker symbol?
ImmuCell Corporation stock trades on NASDAQ under the ticker symbol ICCC.What is ImmuCell Corporation's market capitalization?
ImmuCell Corporation's market capitalization is $93.09M as of November 5, 2026 at 2:29 AM IST.What is ImmuCell Corporation's price-to-earnings (P/E) ratio?
ImmuCell Corporation's price-to-earnings (P/E) ratio is 146.42 as of November 5, 2026.What is ImmuCell Corporation's price-to-book (P/B) ratio?
ImmuCell Corporation's price-to-book (P/B) ratio is 3.05 as of November 5, 2026.Can Indian investors buy ImmuCell Corporation shares?
Yes, You can buy ImmuCell Corporation shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in ImmuCell Corporation shares from India?
Indian investors can buy ImmuCell Corporation shares in three steps: 1. Search ImmuCell Corporation on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from ImmuCell Corporation shares for Indian investors?
Since ImmuCell Corporation trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in ImmuCell Corporation shares via Tickertape?
Indian investors can start investing in ImmuCell Corporation (ICCC) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.9852 shares at the current price of $10.15.
$
₹
$10.150.97% (-0.1)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
146.42
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
3.05
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$0.07
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
0
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
2.57%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Based on consolidated analysts reports
Buy, Sell and Hold recommendations are not available
Price Upside
—
Earnings Growth
—
Rev. Growth
—
Company Profile
Company Profile
ABBV
P/E Ratio
49.14
49.14
1Y Return
32.47%
32.47%
Buy Reco %
79.31
79.31
AMGN
P/E Ratio
28.64
28.64
1Y Return
56.57%
56.57%
Buy Reco %
35.29
35.29
P/E Ratio
—
—
1Y Return
36.15%
36.15%
Buy Reco %
78.57
78.57
P/E Ratio
35.59
35.59
1Y Return
30.2%
30.2%
Buy Reco %
81.25
81.25
P/E Ratio
21.51
21.51
1Y Return
48.38%
48.38%
Buy Reco %
67.85
67.85
Forecast
Forecast
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7.25 | 5.47 | 6.01 | 7.75 | 8.06 | 6.44 | 5.50 | 7.62 | 10.35 | 7.18 |
| Gross Profit | 2.29 | 1.23 | 1.58 | 2.83 | 3.35 | 2.81 | 2.36 | 2.91 | 4.65 | 2.43 |
| Net Income | -0.43 | -1.53 | -0.70 | 0.51 | 1.44 | 0.50 | -0.13 | -2.84 | 1.94 | 1.83 |
| Net Profit Margin | -6.03% | -27.98% | -11.67% | 6.63% | 17.93% | 7.78% | -2.53% | -37.36% | 18.74% | 25.53% |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareBiotechnology
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| ImmuCell Corporation | 146.42 | 3.05 | 0 |
| AbbVie Inc | 49.14 | 50.45 | 0.58 |
| Amgen Inc | 28.64 | 21.55 | 2.77 |
Price Comparison
Price Comparison
Compare ICCC with any stock or ETFCompare ICCC with any stock or ETF
Comparing from
ICCC
ABBV
AMGN